3rd Quarter - Report

MCDERMOTT WILL & SCHULTE LLP for SURESCRIPTS

Period 3rd Quarter 2020 Filed Oct 18, 2020 Signed by Karen Sealander

Official filing
Firm
MCDERMOTT WILL & SCHULTE LLP
Client
SURESCRIPTS
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards. Efforts to ensure timely implementation of the SUPPORT Act requirement for electronic prescribing of controlled substances in the Medicare Part D program beginning January 1, 2021. Efforts to support CMSs proposed adoption of NCPDP SCRIPT Standard Version 2017071 for secure electronic prior authorization transactions for Part D-covered drugs and to ensure that problematic preamble language in the proposed rule is addressed so that electronic prior authorization by non-Part D prescription drug plans is not impeded by the final rule.

LobbyistCovered position, as disclosed
KAREN SEALANDER —
SCOTT AARON WEINSTEIN —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards.

LobbyistCovered position, as disclosed
KAREN SEALANDER —
SCOTT AARON WEINSTEIN —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Science/Technology SCI

Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards.

LobbyistCovered position, as disclosed
KAREN SEALANDER —
SCOTT AARON WEINSTEIN —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.